Hisamitsu Pharmaceutical Co Inc (4530):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hisamitsu Pharmaceutical Co Inc (4530) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10111
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain relieving products, dermatological products, and quasi drugs, among others. Hisamitsu Pharmaceutical provides its products in various forms: patches, gel-patchs, gels, creams and lotions. Its products are indicated to relieve patients from stiff neck, sore shoulders, arthritis, joint pain backache, strains, sprains, muscle fatigue, bruises, muscle pain, simple backache bruises, stiff shoulders, sprains, strains arthritis, bone fracture, and minor frostbite. It operates production facilities, research laboratories, and offices in Japan. The company markets its products in Asia and Oceania, Europe, Middle East & Africa, and the Americas. Hisamitsu Pharmaceutical is headquartered in Tokyo, Japan.

Hisamitsu Pharmaceutical Co Inc (4530) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hisamitsu Pharmaceutical Co Inc, Medical Devices Deals, 2012 to YTD 2018 10
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Noven Pharma Acquires Rights To Minivelle From Novogyne Pharma 12
Partnerships 13
Noven Pharma Enters Into Co-Promotion Agreement With Shionogi For Brisdelle Capsules 13
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 14
Sanofi Forms Joint Venture With Hisamitsu Pharma For OTC Medications 15
Equity Offering 16
Hisamitsu Pharma to Raise USD0.01 Million in Private Placement of Shares 16
Asset Transactions 17
ANI Pharma Acquires Lithobid from Noven Therapeutics for USD12 Million 17
Acquisition 18
Hisamitsu Pharma Acquires 15% Stake In Yutoku Pharma 18
Hisamitsu Pharmaceutical Co Inc – Key Competitors 19
Hisamitsu Pharmaceutical Co Inc – Key Employees 20
Hisamitsu Pharmaceutical Co Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hisamitsu Pharmaceutical Co Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Hisamitsu Pharmaceutical Co Inc, Medical Devices Deals, 2012 to YTD 2018 10
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Noven Pharma Acquires Rights To Minivelle From Novogyne Pharma 12
Noven Pharma Enters Into Co-Promotion Agreement With Shionogi For Brisdelle Capsules 13
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 14
Sanofi Forms Joint Venture With Hisamitsu Pharma For OTC Medications 15
Hisamitsu Pharma to Raise USD0.01 Million in Private Placement of Shares 16
ANI Pharma Acquires Lithobid from Noven Therapeutics for USD12 Million 17
Hisamitsu Pharma Acquires 15% Stake In Yutoku Pharma 18
Hisamitsu Pharmaceutical Co Inc, Key Competitors 19
Hisamitsu Pharmaceutical Co Inc, Key Employees 20
Hisamitsu Pharmaceutical Co Inc, Other Locations 21
Hisamitsu Pharmaceutical Co Inc, Subsidiaries 21
Hisamitsu Pharmaceutical Co Inc, Joint Venture 22

List of Figures
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hisamitsu Pharmaceutical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hisamitsu Pharmaceutical Co Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Hisamitsu Pharmaceutical Co Inc (4530):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adh …
  • Mid-America Apartment Communities Inc (MAA):企業の財務・戦略的SWOT分析
    Summary Mid-America Apartment Communities Inc (MAA) is a real estate investment company that operates apartment homes. The company is engaged in property development, property management, redevelopment, acquisition, sales, marketing and financing. MAA provides web-based and technology driven support …
  • Kernel Holding SA:企業の戦略・SWOT・財務情報
    Kernel Holding SA - Strategy, SWOT and Corporate Finance Report Summary Kernel Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Ramot:製薬・医療:M&Aディール及び事業提携情報
    Summary Ramot is a business engagement center of Tel Aviv University that offers technology transfer services. The center manages new technologies from university laboratories to the domestic and commercial markets. It also offers services which include research and development programs, securing ap …
  • Foraco International SA (FAR):企業の財務・戦略的SWOT分析
    Summary Foraco International SA (Foraco) is a provider of drilling solutions for mining, energy, water and infrastructure projects. The company's drilling solutions include hydrogeological drilling, deep directional drilling, metallurgical sampling and large diameter drilling. It provides geological …
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Protalex Inc (PRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as beleodaq and asidna among others. It offers drugs for the treatment of liver cancer, and treatment and pr …
  • EnBW Energie Baden-Wurttemberg AG (EBK):電力:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Cordy Oilfield Services Inc (CKK):石油・ガス:M&Aディール及び事業提携情報
    Summary Cordy Oilfield Services Inc (Cordy) is an oilfield and construction service provider. The company offers construction and environmental services. Its construction services include underground utilities installation and maintenance, pipeline insulation and reclamation, pump jack maintenance, …
  • AMETEK, Inc.:企業の戦略・SWOT・財務情報
    AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Safety-Kleen Inc:企業の戦略的SWOT分析
    Safety-Kleen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cosumar SA:企業の戦略・SWOT・財務分析
    Cosumar SA - Strategy, SWOT and Corporate Finance Report Summary Cosumar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Soleno Therapeutics Inc (SLNO):医療機器:M&Aディール及び事業提携情報
    Summary Soleno Therapeutics Inc (Soleno), formerly Capnia Inc is a medical equipment company that designs, develops and commercializes novel therapeutic and diagnostic products. The company provides products such as serenz, cosense, and others. It offers serenz which is a hand-held device, which is …
  • EXOR SpA:戦略・SWOT・企業財務分析
    EXOR SpA - Strategy, SWOT and Corporate Finance Report Summary EXOR SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • RWE AG (RWE):企業の財務・戦略的SWOT分析
    RWE AG (RWE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆